Hold the Presses is your online newsportal en brings press releases from around the world. Journalists can use it for free, although it is their responsibilty to check the news. Hold the Presses is in no way responsible for the content of the press releases, the Sender is. We hope you enjoy reading the news we bring you on this website. If a message is published that is not acceptable, we apologize. Please contact us and we will remove the message as soon as possible.

Friday, 10 November 2017

EU Commission: Yves Mersch:=?UTF-8?B?IEV2b2x2aW5nIHJlZ3VsYXRvcnkgZW52aXJvbm1lbnQgZm9yIENDUHMg4oCTIHQ=?==?UTF-8?B?aGUgcGVyc3BlY3RpdmUgb2YgYSBDZW50cmFsIEJhbms=?=

Yves Mersch: Evolving regulatory environment for CCPs – the perspective of a Central Bank
Read more

New medicine for rare inflammatory condition of the oesophagus

Jorveza approved under accelerated assessment

Read more

New medicine to prevent cytomegalovirus disease in stem cell transplant patients

Prevymis recommended for marketing authorisation

Read more

New medicine for multiple sclerosis

Ocrevus is first medicine to receive positive opinion for treatment of patients with early stage of primary progressive multiple sclerosis

Read more

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 6-9 November 2017

Ten medicines recommended for approval, including two orphans

Read more